-
1
-
-
67650502763
-
Selling vaccines: Deciding on who can afford HPV
-
Aneja, H and J Puliyel (2009): "Selling Vaccines: Deciding on Who Can Afford HPV," Indian Pediatrics, 46:647, http://indianpediatrics.net/ july2009/647.pdf
-
(2009)
Indian Pediatrics
, vol.46
, pp. 647
-
-
Aneja, H.1
Puliyel, J.2
-
2
-
-
72649086579
-
The clinical utility of HPV DNA testing in cervical cancer screening strategies
-
Bhatla, N and N Moda (2009): "The Clinical Utility of HPV DNA Testing in Cervical Cancer Screening Strategies", Indian Journal of Medical Research 130(3):261-65.
-
(2009)
Indian Journal of Medical Research
, vol.130
, Issue.3
, pp. 261-265
-
-
Bhatla, N.1
Moda, N.2
-
3
-
-
33750735424
-
The relevance of cervical cancer screening and the future of cervical cancer control in India in the light of the approval of the vaccine against cervical cancer
-
Basu, M (2006): "The Relevance of Cervical Cancer Screening and the Future of Cervical Cancer Control in India in the Light of the Approval of the Vaccine against Cervical Cancer", Indian Journal of Cancer, 43(3):139. (Pubitemid 44701610)
-
(2006)
Indian Journal of Cancer
, vol.43
, Issue.3
, pp. 139
-
-
Basu, M.1
-
4
-
-
72649102750
-
Cervical cancer screening and HPV vaccination: A comprehensive approach to cervical cancer control
-
Basu, P and D Chowdhury (2009): "Cervical Cancer Screening and HPV Vaccination: A Comprehensive Approach to Cervical Cancer Control", Indian Journal of Medical Research, 130:241-46.
-
(2009)
Indian Journal of Medical Research
, vol.130
, pp. 241-246
-
-
Basu, P.1
Chowdhury, D.2
-
5
-
-
84859368642
-
-
Central Drugs Standard Control Organisation, Ministry of Health, Government of India, viewed on 30 July 2010
-
CDSCO (undated): "Guidance for Industry on Submission of Clinical Trial Application for Evaluating Safety and Efficacy", Central Drugs Standard Control Organisation, Ministry of Health, Government of India, viewed on 30 July 2010 (http://cdsco.nic.in/CDSCO-GuidanceForlndustry.pdf).
-
Guidance for Industry on Submission of Clinical Trial Application for Evaluating Safety and Efficacy
-
-
-
6
-
-
77949495486
-
Concerns around the human papilloma virus (HPV) vaccine
-
Dabade, G et al (2010): "Concerns Around the Human Papilloma Virus (HPV) Vaccine", Memorandum, Indian Journal of Medical Ethics, 7(1):38-41.
-
(2010)
Memorandum, Indian Journal of Medical Ethics
, vol.7
, Issue.1
, pp. 38-41
-
-
Dabade, G.1
-
7
-
-
84859358646
-
-
7 April, viewed on 30 July 2010
-
Dhar, A (2010a): "Centre Halts HPV Vaccine Project", The Hindu, 7 April, viewed on 30 July 2010 (http://beta.thehindu.com/news/national/ article391024.ece).
-
(2010)
Centre Halts HPV Vaccine Project
-
-
Dhar, A.1
-
9
-
-
49949118211
-
Human papillomavirus vaccination - Reasons for caution
-
Haug, C J (2008): "Human Papillomavirus Vaccination - Reasons for Caution", New England Journal of Medicine, 359:861-68.
-
(2008)
New England Journal of Medicine
, vol.359
, pp. 861-868
-
-
Haug, C.J.1
-
10
-
-
33947630926
-
-
New Delhi: Indian Council of Medical Research, viewed on 30 July 2010
-
ICMR (2006a): Annual Report 2005-2006 (New Delhi: Indian Council of Medical Research), viewed on 30 July 2010 (http://www.icmrnic.in/annual/2005-06/ hqds/overview.pdf).
-
(2006)
Annual Report 2005-2006
-
-
-
13
-
-
34548402886
-
Human papillomavirus, vaccines and women's health: Questions and cautions
-
DOI 10.1503/cmaj.070944
-
Lippman, A, R Melnychuk, C Shimmin and M Boscoe (2007): "Human Papillomavirus, Vaccines and Women's Health: Questions and Cautions", Canadian Medical Association Journal, 177(5):484-87. (Pubitemid 47359772)
-
(2007)
Canadian Medical Association Journal
, vol.177
, Issue.5
, pp. 484-487
-
-
Lippman, A.1
Melnychuk, R.2
Shimmin, C.3
Boscoe, M.4
-
14
-
-
77952317322
-
"Crisis of speculation: Donors should fund only locally proven vaccine needs and local capacity building", rapid response to P Moszynski (2010): "Drive to vaccinate children in developing countries faces 'acute crisis' because of high costs"
-
Madhavi, Y and N Raghuram (2010): "Crisis of Speculation: Donors Should Fund Only Locally Proven Vaccine Needs and Local Capacity Building", Rapid Response to P Moszynski (2010): "Drive to Vaccinate Children in Developing Countries Faces 'Acute Crisis' Because of High Costs", BMJ, 340: c2576.
-
(2010)
BMJ
, vol.340
-
-
Madhavi, Y.1
Raghuram, N.2
-
16
-
-
84874595101
-
-
NIMS/ICMR: National Institute of Medical Statistics, Indian Council of Medical Research, "Clinical Trials Registry-India", http://www.ctri.in/Clinicaltrials/index.jsp
-
Clinical Trials Registry-India
-
-
-
18
-
-
84859354931
-
-
Program for Appropriate Technology in Health, press release 27 April, viewed on 30 July 2010
-
PATH (2010): "Update: PATH'S HPV Vaccination Project in India", Program for Appropriate Technology in Health, press release 27 April, viewed on 30 July 2010 (http://www.path.org/news/an100422-hpv-india.php).
-
(2010)
Update: PATH'S HPV Vaccination Project in India
-
-
-
21
-
-
84859332511
-
-
Special Correspondent, 10 July, viewed on 30 July 2010
-
Special Correspondent (2009): "Pilot Programme for Vaccination against Cervical Cancer Launched", The Hindu, 10 July, viewed on 30 July 2010 (http://www.hindu.com/2009/07/10/stories/2009071059770500.htm).
-
(2009)
Pilot Programme for Vaccination Against Cervical Cancer Launched
-
-
-
22
-
-
77956033348
-
-
29 April, viewed on 30 July 2010
-
Thacker, T (2010): "Ministry Admits Lapses in HPV Vaccine Trial", The Indian Express, 29 April, viewed on 30 July 2010 (http://www.indianexpress.com/news/ministry-admitslapses-in-hpv-vaccine-trial/ 612823/).
-
(2010)
Ministry Admits Lapses in HPV Vaccine Trial
-
-
Thacker, T.1
-
24
-
-
84859352657
-
-
Human Papillomavirus Bivalent Types 16 and 18 Vaccine, Recombinant, 9 September, viewed on 30 July 2010
-
- (2009a): Vaccines and Related Biological Products Advisory Committee (VRBPAC) Briefing Document Cervarix, Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant, 9 September, viewed on 30 July 2010 (http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/ BloodVaccinesandOtherBiologics/VaccinesandRelatedBiological- ProductsAdvisoryCommittee/UCM181371.pdf).
-
(2009)
Vaccines and Related Biological Products Advisory Committee (VRBPAC) Briefing Document Cervarix
-
-
Thacker, T.1
-
26
-
-
84859336743
-
-
Gardasil, last updated 9 July 2010, viewed on 30 July 2010
-
- (2010): Vaccines, Blood and Biologics, Vaccines, Approved Products, Gardasil, last updated 9 July 2010, viewed on 30 July 2010 (http://www.fda.gov/ BiologicsBloodVaccines/Vaccines/Approved-Products/ucmo94042.htm).
-
(2010)
Vaccines, Blood and Biologics, Vaccines, Approved Products
-
-
Thacker, T.1
-
27
-
-
84859310143
-
-
USNIH (United States National Institutes of Health) www.clinicaltrials. gov
-
-
-
|